Form D · Pharmaceuticals
Provell Pharmaceuticals, LLC
Honey Brook, PA · CIK 0001592082
Offering snapshot reported Feb 14, 2024 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2024 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Aug 15, 2023 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 28, 2023 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jul 11, 2022 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jul 10, 2019 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Dec 3, 2013 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505252
Convertible Note that converts into membership interest of Issuer in accordance with the terms therein.
Source: Form D, filed Feb 14, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James G. Small | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1801 Horeshoe Pike
Honey Brook, PA, 19341
Honey Brook, PA, 19341